Biogen
BIIB
#950
Rank
โ‚ฌ19.78 B
Marketcap
135,16ย โ‚ฌ
Share price
0.44%
Change (1 day)
-34.14%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ10.90 Billion

According to Biogen's latest financial reports the company's total liabilities are โ‚ฌ10.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Biogen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ10.89 B4.68%
2022-12-31โ‚ฌ10.40 B-8.74%
2021-12-31โ‚ฌ11.40 B0.69%
2020-12-31โ‚ฌ11.32 B-8.68%
2019-12-31โ‚ฌ12.40 B15.77%
2018-12-31โ‚ฌ10.71 B16.29%
2017-12-31โ‚ฌ9.21 B-9.84%
2016-12-31โ‚ฌ10.21 B10.29%
2015-12-31โ‚ฌ9.26 B221.87%
2014-12-31โ‚ฌ2.87 B22.59%
2013-12-31โ‚ฌ2.34 B-1.91%
2012-12-31โ‚ฌ2.39 B18.53%
2011-12-31โ‚ฌ2.01 B1.63%
2010-12-31โ‚ฌ1.98 B24.32%
2009-12-31โ‚ฌ1.59 B-15.52%
2008-12-31โ‚ฌ1.89 B-10.73%
2007-12-31โ‚ฌ2.11 B99.32%
2006-12-31โ‚ฌ1.06 B-14.65%
2005-12-31โ‚ฌ1.24 B-27.76%
2004-12-31โ‚ฌ1.72 B-11.4%
2003-12-31โ‚ฌ1.94 B114.18%
2002-12-31โ‚ฌ0.90 B115.63%
2001-12-31โ‚ฌ0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ82.69 B 658.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ34.76 B 218.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ126.78 B 1,062.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ122.09 B 1,019.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ104.48 B 858.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.25 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ54.99 B 404.46%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ2.68 B-75.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.78 B-65.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.63 B-75.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands